Evidence map›Paper›PMID 36414286›Full record

Trial reportBMJ open2022

Cohort profile: CareConekta: a pilot study of a smartphone application to improve engagement in postpartum HIV care in South Africa.

Kate Clouse, Sandisiwe Noholoza, Nkosinathi Ngcobo, Sindiswa Madwayi, Megan Mrubata, Carol S Camlin, Landon Myer, Tamsin K Phillips

Registry-linked trialAbstract readRandomized Controlled Trial
In one paragraph

Trial report in BMJ open, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03836625 (CareConekta), which is not on this map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03836625 nacompletednot on this map

CareConekta: A Pilot Study of a Smartphone App to Improve Engagement in Postpartum HIV Care in South Africa

TypeinterventionalSponsorVanderbilt UniversityRan2019 to 2021Enrolled200ConditionsHIV/AIDS, Pregnancy RelatedArmsCareConekta
3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Trial
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Kate ClouseVanderbilt University School of Nursing, Nashville, TN, USA kate.clouse@vanderbilt.edu.ORCID 0000-0002-0190-7398
Sandisiwe NoholozaDivision of Epidemiology and Biostatistics, School of Public Health, University of Cape Town, Cape Town, South Africa.
Nkosinathi NgcoboDepartment of Internal Medicine, School of Clinical Medicine, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.
Sindiswa MadwayiDivision of Epidemiology and Biostatistics, School of Public Health, University of Cape Town, Cape Town, South Africa.
Megan MrubataDivision of Epidemiology and Biostatistics, School of Public Health, University of Cape Town, Cape Town, South Africa.
Carol S CamlinDepartment of Obstetrics, Gynecology & Reproductive Sciences, University of California San Francisco, San Francisco, California, USA.
Landon MyerDivision of Epidemiology and Biostatistics, School of Public Health, University of Cape Town, Cape Town, South Africa.
Tamsin K PhillipsDivision of Epidemiology and Biostatistics, School of Public Health, University of Cape Town, Cape Town, South Africa.

Funding

The South African National HIV Pregnancy Cohort: evaluating continuity of care among women living with HIVR01HD103466 · NICHD · WITS HEALTH CONSORTIUM (PTY), LTD · PI CLOUSE, KATE, MASKEW, MHAIRI · 2020 to 2024
$1.8M
CareConekta: Mobile health for a mobile populationR34MH118028 · NIMH · VANDERBILT UNIVERSITY · PI CLOUSE, KATE · 2019 to 2021
$631k
NICHD NIH HHS R01 HD103466NIMH NIH HHS R34 MH118028
6 · The paper itself

Abstract

purposePregnant and postpartum women living with HIV in South Africa are at high risk of dropping out of care, particularly after delivery. Population mobility may contribute to disruptions in HIV care, and postpartum women are known to be especially mobile. To improve engagement in HIV care during the peripartum period, we developed CareConekta, a smartphone application (app) that uses GPS coordinates to characterise mobility and allow for real-time intervention. We conducted a randomised controlled pilot study to assess feasibility, acceptability and initial efficacy of the app intervention to improve engagement in HIV care. This cohort profile describes participant enrolment and follow-up, describes the data collected and provides participant characteristics.

participantsWe enrolled 200 pregnant women living with HIV attending routine antenatal care at the Gugulethu Midwife Obstetric Unit in Cape Town, South Africa. Eligible women must have owned smartphones that met the app's technical requirements. Seven participants were withdrawn near enrolment, leaving 193 in the cohort. FINDINGS TO DATE: Data were collected from detailed participant questionnaires at enrolment and follow-up (6 months after delivery), as well as GPS data from the app, and medical records. Follow-up is complete; initial analyses have explored smartphone ownership, preferences and patterns of use among women screened for eligibility and those enrolled in the study. FUTURE PLANS: Additional planned analyses will characterise mobility in the population using the phone GPS data and participant self-reported data. We will assess the impact of mobility on engagement in care for the mother and infant. We also will describe the acceptability and feasibility of the study, including operational lessons learnt. By linking this cohort to the National Health Laboratory Service National HIV Cohort in South Africa, we will continue to assess engagement in care and mobility outcomes for years to come. Collaborations are welcome. TRIAL REGISTRATION NUMBER: NCT03836625.

Indexed as

HIV InfectionsMobile ApplicationsFemaleHumansInfantPilot ProjectsPostpartum PeriodPregnancySmartphoneSouth AfricaEpidemiologyHIV & AIDSMaternal medicinePUBLIC HEALTH

Identifiers

PMID36414286
PMCPMC9685000

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.